Mahmander Q* and Meirzai H
Liquid biopsy represents a revolutionary paradigm shift in the field of cancer detection and monitoring. This non-invasive diagnostic approach leverages the analysis of various components in bodily fluids to detect genetic mutations, circulating tumor cells (CTCs), cell-free DNA (cfDNA), and other biomarkers associated with cancer. In this abstract, we delve into the deep details of liquid biopsy, including its methods and applications. The article highlights the potential impact of liquid biopsy on early cancer detection, treatment monitoring, and tumor profiling. However, challenges in sensitivity, specificity, and standardization must be addressed to unlock its full potential. Despite these challenges, liquid biopsy holds great promise, and on-going research and technological advancements continue to refine its accuracy and broaden its applications. This revolutionary approach has the potential to transform cancer care, offering a less invasive, more accessible, and potentially earlier method of cancer detection and monitoring.
Published Date: 2023-09-30; Received Date: 2023-09-05
